Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2745 (remimazolam) Phase II ICU sedation after surgery
jRCT2080221927Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of remimazolam in None and Post-operative care (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
remimazolam
03
Conditions
Post-operative care
Beyond the preview
Go deeper on jRCT2080221927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221927.